Loading…
Loading…
Company will operate under the Arvia brand, with the Vacterra brand retained exclusively for its hydrovac truck operations CHEYENNE, WY / ACCESS Newswire / August 18, 2026 / Protect Pharmaceutical Corp. (OTCID:PRTT) (the "Company" or "PRTT") today announced that its wholly owned Canadian subsidiary has completed the acquisition of Vacterra Hydrovac Inc. ("Vacterra") and Clearwater Environmental Ltd. ("Clearwater") from Horizon Enterprises Ltd.
ANKARA, Turkey, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. (OTC: PRTT) (“Company”) and Atlantic Logistics announce there will be no merger with KARINCA Logistics.
ANKARA, Turkey, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. (OTC: PRTT) ("Company") announces the appointment of a new CEO, restructuring of the Board of Directors, and looks to finalize the merger agreement with Karinca Logistics - www.karincalogistics.com . The Company appointed Ozgur Ozcan as CEO and Director and George Athanasiadis as Director.
ANKARA, Turkey, July 01, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.'s (OTC: PRTT) (“Company”) President, Ali Yildiz, provides its shareholders with the following informational update: "July 1, 2024 Dear Shareholders: The Company's PCAOB audit for the fiscal year of 2023 is near completion. We have a few items remaining that are required to be completed by the local jurisdiction of the company in Turkey.
ISTANBUL, Turkey, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.'s (OTC: PRTT) President, Ali Yildiz, publishes his February 2024 corporate update letter to Company Shareholders as follows: "February 5, 2024 Dear Shareholders: Management announces that it has finalized its 2021 and 2022 financials, and the audit can be announced as completed. The Company is drafting a Form 10 registration statement that will be filed with the SEC to resume reporting to the SEC.
ISTANBUL, Turkey, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.'s (OTC: PRTT) President, Ali Yildiz, publishes a letter to Company Shareholders as follows: “Dear Shareholders of Protect Pharmaceutical Corp.: We have continued working with respect to finalizing our PCAOB audit. Our auditor has been granted access to the remaining areas that were needed and is finalizing the audit now.
Istanbul, Turkey, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” Ali Yildiz Addresses shareholders of the company.
Istanbul, Turkey, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” Ali Yildiz Addresses shareholders of the company.
No recent filings indexed.